Decoding Death and Dying in People With Dementia by Digital Thanotyping

Recruiting Observational Study
Dementia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Study type
Observational
Participants needed
480 (estimated)
Sponsor
University of Bergen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
How can healthcare professionals recognize that a person with dementia is at the end of life? When people are dying, their physical, mental, and social abilities are gradually declining. No reliable method of predicting perceived dying currently exists although the technology is available (sensors, algorithms). The aim of Decoding Death and Dying in Dementia by Digital thanotyping (5-D) is to pro…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Nursing home resident * \>64 years old * People with dementia or who have a likely diagnosis of dementia * Score of \<4 on the 4 A's Test for Delirium (4AT) will be required for inclusion (no delirium) Exclusion Criteria: * People without dementia or cognitive impairment * P…
Contacts

Bettina S. Husebø, PhD

48094660

bettina.husebo@uib.no

CONTACT

Monica Patrascu, PhD

91198669

monica.patrascu@uib.no

CONTACT